Since GCG encodes the precursor of GLP-1, the observed reduction in GCG and other key EEC markers (CHGA, NEUROD1, PYY) in tumor tissue, combined with these external clinical data, suggests that EECs and incretin hormones may exert an anti-tumor role in colorectal carcinogenesis. This evidence concerns the gene GLP1R and medical procedure.